Health News
Data demonstrating rising youth use of tobacco products
- Details
- Written by FDA Commissioner Scott Gottlieb, M.D. FDA Commissioner Scott Gottlieb, M.D.
- Published: 12 February 2019 12 February 2019
Washington, DC - Today, the U.S. Centers for Disease Control and Prevention (CDC) released additional data from our joint FDA/CDC 2018 National Youth Tobacco Survey.
Strengthening regulation of dietary supplements
- Details
- Written by FDA Commissioner Scott Gottlieb, M.D. FDA Commissioner Scott Gottlieb, M.D.
- Published: 11 February 2019 11 February 2019
Washington, DC - The use of dietary supplements, such as vitamins, minerals or herbs, has become a routine part of the American lifestyle. Three out of every four American consumers take a dietary supplement on a regular basis. For older Americans, the rate rises to four in five. And one in three children take supplements, either given to them by their parents or, commonly in teens, taking them on their own.
FDA authorizes first test to aid in detecting a type of herpes virus in newborns called cytomegalovirus
- Details
- Written by Stephanie Caccomo Stephanie Caccomo
- Published: 02 December 2018 02 December 2018
Washington, DC - Friday the U.S. Food and Drug Administration permitted marketing of a new diagnostic test to aid in detecting a type of herpes virus called cytomegalovirus (CMV) in newborns less than 21 days of age.
Exploring the Bowen Technique for Healing
- Details
- Written by YNN YNN
- Published: 29 December 2018 29 December 2018
Yuma, Arizona - On Thursday, January 10th, the Foothills Library will host “Exploring the Bowen Technique for Healing” at 10:30 a.m. The Bowen technique is a gentle, hands-on approach to healing that signals a response in the brain, creating an impulse to re-align the body. Join certified expert Kasia Voorhies to learn more about this international healing practice that can address every system in the body.
FDA approves treatment for adult patients who have relapsed or refractory acute myeloid leukemia
- Details
- Written by Amanda Turney Amanda Turney
- Published: 01 December 2018 01 December 2018
Washington, DC - The U.S. Food and Drug Administration today approved Xospata (gilteritinib) tablets for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. The FDA also approved an expanded indication for a companion diagnostic, to include use with Xospata.